Avik Pharmaceutical Limited - API Export Market Expansion
How Volza’s market intelligence empowered a pharmaceutical manufacturer to achieve 120% export revenue growth and enter 8 new regulated markets.
About Avik Pharmaceutical Limited
Pioneering excellence in corticosteroid API manufacturing since 1978
Avik Pharmaceutical Limited
Pharmaceutical Manufacturing (APIs)
Vapi, Gujarat, India
1978
API Manufacturer
Mr. Anant Thakore (Chairman)
₹25–100 Crores
51–200 people
Business Obstacles
Navigating regulatory and market complexities in the global API landscape
Project Objectives
Strategic roadmap for global expansion
Analyze international pharmaceutical regulations to prioritize viable markets.
Identify and verify global buyers for specialty APIs.
Benchmark global quality and compliance standards.
Establish regulatory intelligence for timely approvals and sustainable export growth.
Volza's Solution
Data-backed market and competitive insights empowering exporters to achieve rapid, confident expansion
Global demand mapping for corticosteroids and steroidal hormones.
Access to verified pharmaceutical manufacturers and their sourcing patterns.
Insights into quality requirements across different regulatory markets.
Implementation Timeline & Activities
12-month roadmap to global regulatory success
Identification of 8 target markets based on demand and regulatory feasibility.
Sourcing verified data on 250+ pharmaceutical buyers and importers.
Development of quality and documentation standards aligned with global norms.
Support in dossier preparation, lead follow-ups, and strategic partnerships.
Success
Metrics
Results & Impact
Quantitative Outcomes
Export Revenue
+120% growth in international API sales.
Regulatory Approvals
Secured in 8 new regulated markets.
Customer Base
+180% increase in international clients.
Product Portfolio
5 new APIs successfully launched globally.
Market Share
Captured 15% of the global specialty corticosteroids segment.
Strategic Impact
The collaboration between Avik Pharmaceutical Limited and Volza exemplifies how data, intelligence, and regulatory insight can transform export potential into measurable growth. By combining market foresight, buyer validation, and quality benchmarking, Avik not only scaled its exports but established itself as a trusted global leader in specialty APIs.
Volza’s pharmaceutical market intelligence was instrumental in our global expansion. Their regulatory insights helped us navigate complex approval processes in eight new markets, resulting in 120% growth in our API exports. The platform’s pharmaceutical company database connected us with top-tier international partners. 
